These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. In their own words: patient navigator roles in culturally sensitive cancer care. Phillips S; Villalobos AVK; Crawbuck GSN; Pratt-Chapman ML Support Care Cancer; 2019 May; 27(5):1655-1662. PubMed ID: 30109486 [TBL] [Abstract][Full Text] [Related]
44. When can cancer patient treatment nonadherence be considered intentional or unintentional? A scoping review. Wreyford L; Gururajan R; Zhou X PLoS One; 2023; 18(5):e0282180. PubMed ID: 37134109 [TBL] [Abstract][Full Text] [Related]
45. Patient-reported barriers to statin adherence: Excerpts from a motivational interviewing intervention in older adults. Vadhariya A; Paranjpe R; Essien EJ; Johnson ML; Fleming ML; Esse TW; Gallardo E; Serna O; Choi J; Boklage S; Abughosh SM J Am Pharm Assoc (2003); 2021; 61(1):60-67.e1. PubMed ID: 33032947 [TBL] [Abstract][Full Text] [Related]
46. Facilitators and barriers to adherence in the initiation phase of Disease-modifying Antirheumatic Drug (DMARD) use in patients with arthritis who recently started their first DMARD treatment. Pasma A; van 't Spijker A; Luime JJ; Walter MJ; Busschbach JJ; Hazes JM J Rheumatol; 2015 Mar; 42(3):379-85. PubMed ID: 25512473 [TBL] [Abstract][Full Text] [Related]
47. Evaluating patient-reported adherence and outcomes in specialty disease states: A dual-site initiative. Bryan ED; Renfro CP; Anguiano RH; Kumor L; DeClercq J; Choi L; Zuckerman AD J Manag Care Spec Pharm; 2024 Jul; 30(7):710-718. PubMed ID: 38950163 [TBL] [Abstract][Full Text] [Related]
48. Process- and patient-reported outcomes of a multifaceted medication adherence intervention for hypertensive patients in secondary care. Hedegaard U; Hallas J; Ravn-Nielsen LV; Kjeldsen LJ Res Social Adm Pharm; 2016; 12(2):302-18. PubMed ID: 26088274 [TBL] [Abstract][Full Text] [Related]
49. Identification of patients at risk of non-adherence to oral antirheumatic drugs in rheumatoid arthritis using the Compliance Questionnaire in Rheumatology: an ARCO sub-study. Marras C; Monteagudo I; Salvador G; de Toro FJ; Escudero A; Alegre-Sancho JJ; Raya E; Ortiz A; Carmona L; Mestre Y; Cea-Calvo L; Calvo-Alén J Rheumatol Int; 2017 Jul; 37(7):1195-1202. PubMed ID: 28516236 [TBL] [Abstract][Full Text] [Related]
50. Development and validation of motivational messages to improve prescription medication adherence for patients with chronic health problems. Kreps GL; Villagran MM; Zhao X; McHorney CA; Ledford C; Weathers M; Keefe B Patient Educ Couns; 2011 Jun; 83(3):375-81. PubMed ID: 21602010 [TBL] [Abstract][Full Text] [Related]
51. Patient barriers to cancer clinical trial participation and navigator activities to assist. Cartmell KB; Bonilha HS; Simpson KN; Ford ME; Bryant DC; Alberg AJ Adv Cancer Res; 2020; 146():139-166. PubMed ID: 32241387 [TBL] [Abstract][Full Text] [Related]
52. Lay Patient Navigators' Perspectives of Barriers, Facilitators and Training Needs in Initiating Advance Care Planning Conversations With Older Patients With Cancer. Niranjan SJ; Huang CS; Dionne-Odom JN; Halilova KI; Pisu M; Drentea P; Kvale EA; Bevis KS; Butler TW; Partridge EE; Rocque GB J Palliat Care; 2018 Apr; 33(2):70-78. PubMed ID: 29432705 [TBL] [Abstract][Full Text] [Related]
53. The influence of the SARS-CoV-2 lockdown on patients with inflammatory rheumatic diseases on their adherence to immunomodulatory medication: a cross sectional study over 3 months in Germany. Hasseli R; Müller-Ladner U; Keil F; Broll M; Dormann A; Fräbel C; Hermann W; Heinmüller CJ; Hoyer BF; Löffler F; Özden F; Pfeiffer U; Saech J; Schneidereit T; Schlesinger A; Schwarting A; Specker C; Stapfer G; Steinmüller M; Storck-Müller K; Strunk J; Thiele A; Triantafyllias K; Vagedes D; Wassenberg S; Wilden E; Zeglam S; Schmeiser T Rheumatology (Oxford); 2021 Oct; 60(SI):SI51-SI58. PubMed ID: 33704418 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of a patient decision aid for initiating disease modifying anti-rheumatic drugs. Nota I; Drossaert CH; Taal E; Vonkeman HE; Haagsma CJ; van de Laar MA Arthritis Res Ther; 2016 Oct; 18(1):252. PubMed ID: 27793171 [TBL] [Abstract][Full Text] [Related]
55. Lack of Consistent Investment in Federal Insurance Navigator Program Undermines Navigators' Equity Work in Vulnerable Communities. van Eijk MS; Kett PM; Prueher L; Frogner BK; Guenther GA J Public Health Manag Pract; 2022 Jul-Aug 01; 28(4):399-405. PubMed ID: 35121713 [TBL] [Abstract][Full Text] [Related]
56. Rheumatology: the expectations and preferences of patients for their follow-up monitoring care: a qualitative study to determine the dimensions of patient satisfaction. Arthur V; Clifford C J Clin Nurs; 2004 Feb; 13(2):234-42. PubMed ID: 14723676 [TBL] [Abstract][Full Text] [Related]
57. Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study. Hodges JR; Phillips SM; Norell S; Nwosu C; Khan H; Luo L; Badawy SM; King A; Tanabe P; Treadwell M; Rojas Smith L; Calhoun C; Hankins JS; Porter J Blood Adv; 2020 Sep; 4(18):4463-4473. PubMed ID: 32941646 [TBL] [Abstract][Full Text] [Related]
58. The Role of the Physician in Patient Perceptions of Barriers to Primary Adherence With Acne Medications. Ryskina KL; Goldberg E; Lott B; Hermann D; Barbieri JS; Lipoff JB JAMA Dermatol; 2018 Apr; 154(4):456-459. PubMed ID: 29490358 [TBL] [Abstract][Full Text] [Related]
59. Patient-specific factors relating to medication adherence in a post-percutaneous coronary intervention cohort. Rushworth GF; Cunningham S; Mort A; Rudd I; Leslie SJ Int J Pharm Pract; 2012 Aug; 20(4):226-37. PubMed ID: 22775519 [TBL] [Abstract][Full Text] [Related]
60. Multifaceted intervention including motivational interviewing to support medication adherence after stroke/transient ischemic attack: a randomized trial. Hedegaard U; Kjeldsen LJ; Pottegård A; Bak S; Hallas J Cerebrovasc Dis Extra; 2014; 4(3):221-34. PubMed ID: 25598772 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]